Tectonic Therapeutic (TECX) Asset Writedowns and Impairment (2018 - 2023)
Tectonic Therapeutic (TECX) reported Asset Writedowns and Impairment of $35000.0 for Q4 2023, down 85.11% quarter-over-quarter from $235000.0 in Q1 2018.
Tectonic Therapeutic (TECX) Asset Writedowns and Impairment (2018 - 2023) Analysis & Trends
Tectonic Therapeutic (TECX) has 2 years of Asset Writedowns and Impairment data on file, last reported at $35000.0 in Q4 2023.
- Asset Writedowns and Impairment for Q4 2023 came in at $35000.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2023 was $35000.0 (changed N/A YoY), and the FY2023 annual result was $1.9 million, changed N/A from the prior year.
- Asset Writedowns and Impairment slipped to $35000.0 in Q4 2023 per TECX's latest filing, from $235000.0 in the prior quarter.
- Over five years, Asset Writedowns and Impairment peaked at $35000.0 in Q4 2023 and troughed at $35000.0 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Tectonic Therapeutic | 528.16 Mn | 291.27 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 35,000.00 |
| Dec 31, 2023 | 35,000.00 |
| Mar 31, 2018 | 235,000.00 |
| Mar 31, 2018 | 235,000.00 |